naringenin has been researched along with Urinary Bladder Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hseu, YC; Hsu, LS; Huang, YC; Kuo, CC; Liao, AC; Liu, JY; Yeh, CW | 1 |
1 other study(ies) available for naringenin and Urinary Bladder Neoplasms
Article | Year |
---|---|
Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP‑2.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Flavanones; Humans; Matrix Metalloproteinase 2; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; Urinary Bladder Neoplasms | 2014 |